Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Int J Mol Sci ; 22(13)2021 Jul 05.
Article in English | MEDLINE | ID: covidwho-1295860

ABSTRACT

Thousands of drugs and nutraceuticals along with their combinations can be used to select candidate therapeutics for targeting the transmission, proliferation and the fatal or severe symptoms of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in order to reduce the unacceptably high mortality rate observed in the coronavirus disease 2019 (COVID-19) pandemic and its associated negative effects on daily life worldwide [...].


Subject(s)
Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , COVID-19 Drug Treatment , COVID-19/etiology , Drug Approval , Drug Therapy, Combination , Host-Pathogen Interactions/drug effects , Humans , Molecular Targeted Therapy , SARS-CoV-2/drug effects , SARS-CoV-2/pathogenicity , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL